These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2922108)

  • 1. Cholecystokinin system in striatal-nigral neuronal networks: infusion of quinolinic acid into rat striatum.
    Takita M; Kato T
    Neuropeptides; 1989 Jan; 13(1):71-4. PubMed ID: 2922108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracerebral quinolinic acid injection in the rat: effects on dopaminergic neurons.
    Mazzari S; Aldinio C; Beccaro M; Toffano G; Schwarcz R
    Brain Res; 1986 Aug; 380(2):309-16. PubMed ID: 2944562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nigrostriatal pathway modulates striatum vulnerability to quinolinic acid.
    Buisson A; Pateau V; Plotkine M; Boulu RG
    Neurosci Lett; 1991 Oct; 131(2):257-9. PubMed ID: 1837072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Striatal lesions and transplants demonstrate that cholecystokinin receptors are localized on intrinsic striatal neurones: a quantitative autoradiographic study.
    Beresford IJ; Hall MD; Clark CR; Hill RG; Hughes J; Sirinathsinghji DJ
    Neuropeptides; 1987; 10(2):109-36. PubMed ID: 2960910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of acute haloperidol on the gamma-aminobutyric acid system in rat striatum and substantia nigra.
    Kim JS; Hassler R
    Brain Res; 1975 Apr; 88(1):150-3. PubMed ID: 1122395
    [No Abstract]   [Full Text] [Related]  

  • 6. Topography of substantia nigra innervation by D1 receptor-containing striatal neurons.
    Altar CA; Hauser K
    Brain Res; 1987 Apr; 410(1):1-11. PubMed ID: 2953407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quinolinic acid lesions of rat striatum abolish D1- and D2-dopamine receptor-mediated catalepsy.
    Calderon SF; Sanberg PR; Norman AB
    Brain Res; 1988 May; 450(1-2):403-7. PubMed ID: 2969764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of BDNF and NT-4/5 on striatonigral neuropeptides or nigral GABA neurons in vivo.
    Arenas E; Akerud P; Wong V; Boylan C; Persson H; Lindsay RM; Altar CA
    Eur J Neurosci; 1996 Aug; 8(8):1707-17. PubMed ID: 8921261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical and anatomical changes in the striatum and substantia nigra following quinolinic acid lesions in the striatum of the rat: a detailed time course of the cellular and GABA(A) receptor changes.
    Brickell KL; Nicholson LF; Waldvogel HJ; Faull RL
    J Chem Neuroanat; 1999 Oct; 17(2):75-97. PubMed ID: 10585160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basal ganglia lesions in the rat: effects on quinolinic acid metabolism.
    Schwarcz R; Okuno E; White RJ
    Brain Res; 1989 Jun; 490(1):103-9. PubMed ID: 2527078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway--II. Differential localization of dopamine and cholecystokinin receptors.
    Beresford IJ; Davenport AP; Sirinathsinghji DJ; Hall MD; Hill RG; Hughes J
    Neuroscience; 1988 Oct; 27(1):129-43. PubMed ID: 3264392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiological effects of cholecystokinin octapeptide on identified rat nigrostriatal dopaminergic neurons.
    Freeman AS; Chiodo LA
    Brain Res; 1988 Jan; 439(1-2):266-74. PubMed ID: 3359189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of GABA and L-glutamic acid on the potassium-evoked in vitro release of substance P- and neurokinin A-like immunoreactivities are different in the rat striatum and substantia nigra.
    Humpel C; Saria A
    Neurosci Lett; 1989 Oct; 105(1-2):159-63. PubMed ID: 2484728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Morphological picture of lesions to substantia nigra of rats following intracardial administration of quinolinic acid].
    Markiewicz D; Beskid M
    Pol Tyg Lek; 1989 Apr; 44(10-11):262-4. PubMed ID: 2530499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time- and dose-dependent 45Ca2+ accumulation in rat striatum and substantia nigra after an intrastriatal injection of quinolinic acid.
    Gramsbergen JB; van der Sluijs-Gelling AJ
    Exp Neurol; 1993 Jun; 121(2):261-9. PubMed ID: 8339777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-HT1D receptors in the guinea pig brain: pre- and postsynaptic localizations in the striatonigral pathway.
    Waeber C; Zhang LA; Palacios JM
    Brain Res; 1990 Oct; 528(2):197-206. PubMed ID: 2148704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional changes in rat nigral GABA(A) receptors induced by degeneration of the striatonigral GABAergic pathway: an electrophysiological study of receptors incorporated into Xenopus oocytes.
    Sanna E; Motzo C; Usala M; Pau D; Cagetti E; Biggio G
    J Neurochem; 1998 Jun; 70(6):2539-44. PubMed ID: 9603220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of neurotensin-containing neurons in the rat striatum. Effects of unilateral striatal lesions with quinolinic acid and ibotenic acid on neurotensin content and its binding site density.
    Masuo Y; Montagne MN; Pélaprat D; Scherman D; Rostène W
    Brain Res; 1990 Jun; 520(1-2):6-13. PubMed ID: 2169955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quinolinic acid does not spare striatal neuropeptide Y-immunoreactive neurons.
    Boegman RJ; Smith Y; Parent A
    Brain Res; 1987 Jul; 415(1):178-82. PubMed ID: 2957024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurokinin A and substance P in striato-nigral neurons in rat brain.
    Lindefors N; Brodin E; Ungerstedt U
    Neuropeptides; 1986; 8(2):127-32. PubMed ID: 2429229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.